Comparative study of different anticoagulants and coagulants in the evaluation of clinical application of platelet-rich plasma (PRP) standardization
To investigate the impact of different anticoagulants and coagulants with autologous platelet-rich plasma (PRP) in order to evaluate the clinical application of PRP standardization. Bone marrow stem cells (BMSCs) were seeded into autologous PRP gel scaffolds with different anticoagulants (EDTA, heparin sodium HS, and sodium citrate SC) as well as control group (the whole blood group). Quality of PRP was evaluated and flow cytometric assay was used to detect the activity of the platelet (CD62p, PAC-1). BMSCs were also seeded into PRP with different coagulants (Thrombin, Collagen-I, ADP) as well as PRP un-activated (negative group) and L-DMEM complete culture without PRP (control group). The effects of different coagulants with PRP on proliferation, osteogenic differentiation of BMSCs were analyzed by methyl thiazolyl tetrazolium assay (MTT), ALP staining, Von Kossa staining, Confocal microscopic observation, RT-PCR and Western Blot at the morphological, cellular and molecular levels. Different anticoagulants (EDTA, HS, and SC) could affect the quality of PRP. EDTA group revealed the best quality and activity (CD62p, PAC-1). With different coagulants (Thrombin, Collagen-I and ADP) in the proliferation of BMSCs, the MTT assay showed that the proliferation of BMSCs was increased in all groups with time. On the sixth day of culture, the cell number of each PRP group was significantly higher than that in the control group (P < 0.05), while the most rapidly increasing was found in Collagen-I group. The cumulative release of growth factor (TGF-β1, PDGF) at each time point in the PRP gel of the four groups was higher than that in the control group (P < 0.05). Collagen-I was considered as the best PRP coagulant. When thrombin was used as a platelet coagulant, the release of growth factor in PRP was rapid and direct, while the release of growth factor in Collagen-I-activated PRP was sustained and slow, and the total release of ADP-activated PRP growth factors was the lowest. The study demonstrated the similar outcome in osteogenic differentiation. In terms of gene expression and western bolt, the PCR results showed that the expression levels of OCN gene and RUNX2 protein in each PRP group were higher than that in the control group (P < 0.05). Different anticoagulants caused different degrees of lysis and spontaneous activation of platelets, which lead to different quality of PRP. Compared with HS and SC, EDTA could maintain the structural integrity of platelets, reduce their spontaneous activation, and increase the release of PRP growth factors for a longer period of time, thus ensuring the biomass of PRP. In addition, different coagulants also showed different results in the proliferation as well as osteogenic differentiation of BMSCs. Compared with Thrombin and ADP, Collagen-I may be a better choice.
KeywordsPlatelet-rich plasma Bone marrow stem cell Anticoagulants Coagulants
Bone marrow stem cells
Methyl thiazolyl tetrazolium assay
Transforming growth factor
Platelet-derived growth factor
Radio immuno precipitation assay
Sodium dodecyl sulfate
Thrombin receptor agonist peptide-6
ZL: Guarantor of integrity of the entire study; study concepts; study design; definition of intellectual content; manuscript review. NZ and KW: Literature research; clinical studies; experimental studies. NZ: Data acquisition; manuscript preparation; manuscript editing. NZ, KW and TL: Data analysis; statistical analysis.
This study was funded by the specialized Research Fund for Military Medicine Innovation (Grant No. 13CXZ030).
Compliance with ethical standards
Conflict of interest
The authors declare they have no conflict of interest.
All applicable international, national, and/or institutional guidelines for the care and use of animals were followed.
- An S, Huang X, Gao Y, Ling J, Huang Y, Xiao Y (2015) FGF-2 induces the proliferation of human periodontal ligament cells and modulates their osteoblastic phenotype by affecting Runx2 expression in the presence and absence of osteogenic inducers. Int J Mol Med 36(3):705–711CrossRefPubMedPubMedCentralGoogle Scholar
- Dohan Ehrenfest DM, Bielecki T, Jimbo R, Barbé G, Del Corso M, Inchingolo F, Sammartino G (2012) Do the fibrin architecture and leukocyte content influence the growth factor release of platelet concentrates? An evidence-based answer comparing a pure platelet-rich plasma (P-PRP) gel and a leukocyte- and platelet-rich fibrin (L-PRF). Curr Pharm Biotechnol 13(7):1145–1152CrossRefPubMedGoogle Scholar
- Frelinger AL 3rd, Torres AS, Caiafa A, Morton CA, Berny-Lang MA, Gerrits AJ, Carmichael SL, Neculaes VB, Michelson AD (2016) Platelet-rich plasma stimulated by pulse electric fields: Platelet activation, procoagulant markers, growth factor release and cell proliferation. Platelets 27(2):128–135PubMedGoogle Scholar
- Gigout T, Didelon J, Latger V, Claise C, Schooneman F, Paulus F, Stoltz JF (1998) New automatic test for the study of platelet response to variations in osmotic pressure: application in the evaluation of the viability of platelet concentrates. Transfus Clin Biol 5(5):336–345CrossRefPubMedGoogle Scholar
- Koch FP, Merkel C, Al-Nawas B, Smeets R, Ziebart T, Walter C, Wagner W (2011) Zoledronate, ibandronate and clodronate enhance osteoblast differentiation in a dose dependent manner—a quantitative in vitro gene expression analysis of Dlx5, Runx2, OCN, MSX1 and MSX2. J Craniomaxillofac Surg 39(8):562–569CrossRefPubMedGoogle Scholar
- Koch FP, Weinbach C, Hustert E, Al-Nawas B, Wagner W (2012) GDF-5 and BMP-2 regulate bone cell differentiation by gene expression of MSX1, MSX2, Dlx5, and Runx2 and influence OCN gene expression in vitro. Int J Periodontics Restor Dent 32(3):285–293Google Scholar
- Sugaya H, Yoshioka T, Kato T, Taniguchi Y, Kumagai H, Hyodo K, Ohneda O, Yamazaki M, Mishima H (2018) Comparative analysis of cellular and growth factor composition in bone marrow aspirate concentrate and platelet-rich plasma. Bone Marrow Res 25(2018):1549826Google Scholar
- Tohidnezhad M, Bayer A, Rasuo B, Hock JVP, Kweider N, Fragoulis A, Sönmez TT, Jahr H, Pufe T, Lippross S (2017) Platelet-released growth factors modulate the secretion of cytokines in synoviocytes under inflammatory joint disease. Mediators Inflamm 2017:1046438CrossRefPubMedPubMedCentralGoogle Scholar